120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
Data from the three studies formed the basis of the company's application for approval by regulatory agencies
Glofitamab has the potential to offer a readily available, fixed-duration CD20xCD3 bispecific antibody treatment approach for people with aggressive lymphoma
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform
Successfully removed peanut from the child’s left lung through bronchoscopy
Subscribe To Our Newsletter & Stay Updated
